Hemorrhagic Complications in Emergency Department Patients Who Are Receiving Dabigatran Compared With Warfarin
Authors:
- Steven D. SalhanickSSSteven D. Salhanick
- Maureen ChaseMCMaureen Chase
- Michael GanetskyMGMichael Ganetsky
- 1 April 2013
- journal article
- research article
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 61 (4) , 475-479
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Bleeding Risk with Dabigatran in the Frail ElderlyNew England Journal of Medicine, 2012
- Acutely Injured Patients on DabigatranNew England Journal of Medicine, 2011
- Dabigatran: Review of Pharmacology and Management of Bleeding Complications of This Novel Oral AnticoagulantJournal of Medical Toxicology, 2011
- Anticoagulant Options — Why the FDA Approved a Higher but Not a Lower Dose of DabigatranNew England Journal of Medicine, 2011
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009
- The anticoagulants marketNature Reviews Drug Discovery, 2009
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007